Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05584553
Other study ID # MDRG2017-89MS-70SM
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date December 2, 2022
Est. completion date June 30, 2024

Study information

Verified date April 2023
Source Zimmer Biomet
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is a multicenter, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to collect data confirming safety, performance and clinical benefits of the ToggleLoc 2.9 mm and the JuggerLoc Soft Tissue Systems when used for soft tissue to bone fixation in the shoulder. The primary objective is the assessment of performance by analyzing soft tissue to bone healing in the shoulder. The secondary objective is the assessment of safety and clinical benefits. Safety will be evaluated by recording and analyzing the incidence and frequency of complications and adverse events. Relation of the events to device, instrumentation and/or procedure will be specified. Clinical benefits will be assessed by recording patient-reported outcome measures (PROMs) at the longest follow-up after surgery (minimum one year).


Description:

The ToggleLoc 2.9 mm and JuggerLoc Soft Tissue devices consist of non-resorbable devices intended to aid in arthroscopic and orthopaedic reconstructive procedures requiring soft tissue to bone fixation. The clinical purpose is to restore the function and flexibility of the shoulder requiring soft tissue to bone fixation and to relieve pain that cannot be controlled by other treatments. Three sites will be involved in this study. The aim is to include a total of 206 (103 cases operated with the ToggleLoc 2.9 mm and 103 cases operated with the JuggerLoc in the shoulder) consecutive series cases. All potential study subjects will be required to participate in the Informed Consent Process. Baseline data from the preop and intraop will be available in medical notes. The patients will be asked to complete patient questionnaires during a minimum 1 year follow up visit/phone call. In addition, any complications and adverse events that occured since the surgery will also be collected during the follow-up visit/phone call.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 206
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients that received the ToggleLoc 2.9 mm and/or the JuggerLoc Soft Tissue devices for soft tissue to bone fixation in the shoulder. - Patients 18 years or older and skeletally mature. - Patients capable of understanding the surgeon's explanations and following his/her instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study. Exclusion Criteria: - Infection. - Patient conditions including blood supply limitations, and insufficient quantity or quality of bone or soft tissue. - Patients with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions. - Foreign body sensitivity. Where material sensitivity is suspected, testing is to be completed prior to implantation of the device. - Patients who are unwilling or unable to give consent, or to comply with the follow-up program. - Patients who have any condition that would in the judgment of the Investigator place the patient at undue risk or interfere with the study. - Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant). - Off-label use.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ToggleLoc 2.9 mm soft tissue device
The ToggleLoc 2.9 mm Soft Tissue devices consist of non-resorbable devices intended to aid in arthroscopic and orthopaedic reconstructive procedures requiring soft tissue to bone fixation.
JuggerLoc soft tissue device
The JuggerLoc Soft Tissue devices consist of non-resorbable devices intended to aid in arthroscopic and orthopaedic reconstructive procedures requiring soft tissue to bone fixation.

Locations

Country Name City State
Spain Centro Médico Quirónsalud Alicante
Spain Hospital Universitario Quirónsalud Madrid
United States Advanced Bone and Joint Saint Peters Missouri

Sponsors (1)

Lead Sponsor Collaborator
Zimmer Biomet

Countries where clinical trial is conducted

United States,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Soft tissue to bone healing in the shoulder Assessment of performance by analyzing soft tissue to bone healing in the shoulder. The principal investigator will clinically evaluate the study shoulder to assess if soft tissue to bone healing has occurred using a assessment of pain. Pain will be measured from none (no pain) to severe. From operation to the study completion, minimum 1 year post-op.
Secondary Incidence of revisions Safety will be evaluated by recording and analyzing the incidence of revisions. A Kaplan Meier survival curve will be calculated. The Kaplan-Meier involves computing of probabilities of occurrence of revision at a certain point of time. From operation to the study completion, minimum 1 year post-op.
Secondary EuroQol five-dimensional Health Questionnaire (EQ-5D-5L) Clinical benefits will be assessed by recording patient-reported outcome measures (PROMs). The EuroQol five-dimensional Health Questionnaire (EQ-5D-5L): is a generic instrument. The EQ is scored on a 0 to 100 mm scale representing "the worst..." and "the best health you can imagine", respectively. From pre-operative to the study completion, minimum 1 year post-op.
Secondary Oxford Shoulder Score (OSS) Clinical benefits will be assessed by recording patient-reported outcome measures (PROMs). the Oxford Shoulder Score (OSS) is a 12-item, each with 5 potential answers specifically designed and developed for assessing outcomes of shoulder surgery. The score will be on a scale from 0 (worst) to 48 (best). From pre-operative to the study completion, minimum 1 year post-op.
See also
  Status Clinical Trial Phase
Withdrawn NCT04073212 - Dry Needling and Exercise Versus Traditional Physical Therapy for Biceps Tendinitis N/A
Active, not recruiting NCT05519228 - PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm in the Elbow
Terminated NCT03529162 - A Prospective Study Comparing Suture Anchor and Soft Tissue Pectoralis Major Tendon Techniques for Biceps Tenodesis N/A
Recruiting NCT05370183 - Tenotomy of Biceps' Long Head by Mini-optics in Consultation (Hyperambulatory): What Advantage Compared to the Operating Room? N/A
Recruiting NCT06446336 - Creation of a Pre-operative Score, the HASS Score, for Injuries Reliable Diagnosis of Long Biceps Tendon
Completed NCT04650477 - Forearm Position in Subpectoral Biceps Tenodesis N/A